BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 2509473)

  • 1. A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo.
    Singh Y; Chaudhary VK; Leppla SH
    J Biol Chem; 1989 Nov; 264(32):19103-7. PubMed ID: 2509473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The carboxyl-terminal end of protective antigen is required for receptor binding and anthrax toxin activity.
    Singh Y; Klimpel KR; Quinn CP; Chaudhary VK; Leppla SH
    J Biol Chem; 1991 Aug; 266(23):15493-7. PubMed ID: 1651334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bacillus anthracis strain deleted for six proteases serves as an effective host for production of recombinant proteins.
    Pomerantsev AP; Pomerantseva OM; Moayeri M; Fattah R; Tallant C; Leppla SH
    Protein Expr Purif; 2011 Nov; 80(1):80-90. PubMed ID: 21827967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthrax toxin.
    Bhatnagar R; Batra S
    Crit Rev Microbiol; 2001; 27(3):167-200. PubMed ID: 11596878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus anthracis Virulence Regulator AtxA Binds Specifically to the
    McCall RM; Sievers ME; Fattah R; Ghirlando R; Pomerantsev AP; Leppla SH
    J Bacteriol; 2019 Dec; 201(23):. PubMed ID: 31570528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides.
    Arora N; Leppla SH
    J Biol Chem; 1993 Feb; 268(5):3334-41. PubMed ID: 8429009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin.
    Klimpel KR; Molloy SS; Thomas G; Leppla SH
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10277-81. PubMed ID: 1438214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of anthrax toxin gene expression by the transition state regulator abrB.
    Saile E; Koehler TM
    J Bacteriol; 2002 Jan; 184(2):370-80. PubMed ID: 11751813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive expression of protective antigen gene of Bacillus anthracis in Escherichia coli.
    Chauhan V; Singh A; Waheed SM; Singh S; Bhatnagar R
    Biochem Biophys Res Commun; 2001 May; 283(2):308-15. PubMed ID: 11327699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of recombinant lethal factor of
    Gholami M; Moghbeli M; Kafilzadeh F; Kargar M; Torbati MB; Tavizi A; Bellevile S; Hatami J; Eslami Z
    Prep Biochem Biotechnol; 2021; 51(1):9-15. PubMed ID: 32393098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of toxin functional domains in anthrax pathogenesis.
    Brossier F; Weber-Levy M; Mock M; Sirard JC
    Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of protease-treated Bacillus anthracis protective antigen.
    Novak JM; Stein MP; Little SF; Leppla SH; Friedlander AM
    J Biol Chem; 1992 Aug; 267(24):17186-93. PubMed ID: 1512256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of deletion of the edema factor on Bacillus anthracis pathogenicity in guinea pigs and rabbits.
    Levy H; Weiss S; Altboum Z; Schlomovitz J; Rothschild N; Glinert I; Sittner A; Kobiler D
    Microb Pathog; 2012 Jan; 52(1):55-60. PubMed ID: 22020310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin.
    Varughese M; Teixeira AV; Liu S; Leppla SH
    Infect Immun; 1999 Apr; 67(4):1860-5. PubMed ID: 10085028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of anthrax lethal factor gene by osmolyte induction.
    Singh A; Singh S; Waheed SM; Khandelwal P; Bhatnagar R
    FEMS Microbiol Lett; 2002 Apr; 209(2):301-5. PubMed ID: 12007822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor.
    Singh Y; Klimpel KR; Arora N; Sharma M; Leppla SH
    J Biol Chem; 1994 Nov; 269(46):29039-46. PubMed ID: 7961869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
    Gupta M; Alam S; Bhatnagar R
    Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
    Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and characterization of a protective antigen-deficient Bacillus anthracis strain.
    Cataldi A; Labruyère E; Mock M
    Mol Microbiol; 1990 Jul; 4(7):1111-7. PubMed ID: 2122174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.